Mechanisms of immunotherapy and surrogate markers

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 66, Issue SUPPL. 95, 2011, Pages 25-27

  Till, S ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Immunological mechanisms; immunotherapy; laboratory biomarkers; surrogate efficacy markers

Indexed keywords

ALLERGEN; BIOLOGICAL MARKER; BIRCH POLLEN ANTIGEN; GRASS POLLEN EXTRACT; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G4; INTERLEUKIN 10; POLLEN ANTIGEN; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; VACCINE;

ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; BIRCH; CELLULAR IMMUNITY; DRUG MECHANISM; DRUG MONITORING; DRUG RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOTHERAPY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE;

ALLERGENS; BIOLOGICAL MARKERS; DESENSITIZATION, IMMUNOLOGIC; HUMANS; IMMUNE TOLERANCE; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL;

EID: 79958795018     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2011.02627.x     Document Type: Article

References (9)

1. Francis JN, James LK, Paraskevopoulos G, Wong C, Calderon MA, Durham SR, et al., Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity. J Allergy Clin Immunol 2008; 121: 1120-1155.
2. Aslam A, Chan H, Warrell DA, Misbah S, Ogg GS,. Tracking antigen-specific T-cells during clinical tolerance induction in humans. PLoS ONE 2010; 5:e11028.
3. Bohle B, Kinaciyan T, Gerstmayr M, Radakovics A, Jahn-Schmid B, Ebner C,. Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation. J Allergy Clin Immunol 2007; 120: 707-713. (Pubitemid 47320765)
4. O'Hehir RE, Gardner LM, de Leon MP, Hales BJ, Biondo M, Douglass JA, et al., House dust mite sublingual immunotherapy: the role for transforming growth factor-beta and functional regulatory T cells. Am J Respir Crit Care Med 2009; 180: 936-947.
5. Till SJ,. In press.
6. Frew AJ, Powell RJ, Corrigan CJ, Durham SR,. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006; 117: 319-325. (Pubitemid 43190146)
7. Lima MT, Wilson D, Pitkin L, Roberts A, Nouri-Aria K, Jacobson M, et al., Grass pollen sublingual immunotherapy for seasonal rhinoconjunctivitis: a randomized controlled trial. Clin Exp Allergy 2002; 32: 507-514. (Pubitemid 34429567)
8. James L, Shamji MH, Walker SM, Wilson DR, Wachholz PA, Francis JN, et al., Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies. J Allergy Clin Immunol 2011; 127: 509-516.
9. Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001; 69: 89-95.